Tailored light therapy for treating inoperable lung cancer with airway obstruction
Patient tailored near real-time image-based treatment for interstitial PDT of Inoperable Cancer with Airway Obstruction - Phase IIa
['FUNDING_SBIR_2'] · SIMPHOTEK, INC. · NIH-10468238
This study is testing a new light therapy for people with inoperable lung cancer that blocks airways, making it more effective by customizing the treatment to fit each patient's unique needs during the procedure.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | SIMPHOTEK, INC. (nih funded) |
| Locations | 1 site (NEWARK, UNITED STATES) |
| Trial ID | NIH-10468238 on ClinicalTrials.gov |
What this research studies
This research focuses on improving treatment for patients with inoperable lung cancer that causes airway obstruction by using a specialized light therapy called interstitial photodynamic therapy (I-PDT). The approach involves real-time adjustments to the treatment based on individual patient characteristics, such as the optical properties of their tumors and the placement of treatment fibers. By utilizing advanced software, the treatment can be personalized to enhance its effectiveness during the procedure. The study aims to demonstrate the benefits of this tailored approach in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with solid malignancies in the lung that are causing central airway obstruction.
Not a fit: Patients with operable lung cancer or those without airway obstruction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment options for patients with inoperable lung cancer, potentially improving their quality of life and survival rates.
How similar studies have performed: Previous research has shown promise in using photodynamic therapy for cancer treatment, but this specific approach utilizing real-time adjustments is relatively novel.
Where this research is happening
NEWARK, UNITED STATES
- SIMPHOTEK, INC. — NEWARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: POTASEK, MARY — SIMPHOTEK, INC.
- Study coordinator: POTASEK, MARY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, neoplasm/cancer